Literature DB >> 34862558

Radiomic Features Associated with Extent of Resection in Glioma Surgery.

Giovanni Muscas1, Simone Orlandini2, Eleonora Becattini2, Francesca Battista2, Victor E Staartjes3,4, Carlo Serra3,4, Alessandro Della Puppa2.   

Abstract

Radiomics defines a set of techniques for extraction and quantification of digital medical data in an automated and reproducible way. Its goal is to detect features potentially related to a clinical task, like classification, diagnosis, prognosis, and response to treatment, going beyond the intrinsic limits of operator-dependency and qualitative description of conventional radiological evaluation on a mesoscopic scale. In the field of neuro-oncology, researchers have tried to create prognostic models for a better tumor diagnosis, histological and biomolecular classification, prediction of response to treatment, and identification of disease relapse. Concerning glioma surgery, the most significant aid that radiomics can give to surgery is to improve tumor extension detection and identify areas that are more prone to recurrence to increase the extent of tumor resection, thereby ameliorating the patients' prognosis. This chapter aims to review the fundamentals of radiomics models' creation, the latest advance of radiomics in neuro-oncology, and possible radiomic features associated with the extent of resection in the brain gliomas.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Brain glioma; Extent of resection; Machine learning; Radiomics; Surgery

Mesh:

Year:  2022        PMID: 34862558     DOI: 10.1007/978-3-030-85292-4_38

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  39 in total

Review 1.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

2.  Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma.

Authors:  Philipp Kickingereder; Ulf Neuberger; David Bonekamp; Paula L Piechotta; Michael Götz; Antje Wick; Martin Sill; Annekathrin Kratz; Russell T Shinohara; David T W Jones; Alexander Radbruch; John Muschelli; Andreas Unterberg; Jürgen Debus; Heinz-Peter Schlemmer; Christel Herold-Mende; Stefan Pfister; Andreas von Deimling; Wolfgang Wick; David Capper; Klaus H Maier-Hein; Martin Bendszus
Journal:  Neuro Oncol       Date:  2018-05-18       Impact factor: 12.300

Review 3.  The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II).

Authors:  Tanvi Vaidya; Archi Agrawal; Shivani Mahajan; M H Thakur; Abhishek Mahajan
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

4.  Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels.

Authors:  Serdar Bozdag; Aiguo Li; Gregory Riddick; Yuri Kotliarov; Mehmet Baysan; Fabio M Iwamoto; Margaret C Cam; Svetlana Kotliarova; Howard A Fine
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

5.  Magnetic Resonance Imaging-Based Radiomic Profiles Predict Patient Prognosis in Newly Diagnosed Glioblastoma Before Therapy.

Authors:  Sean D McGarry; Sarah L Hurrell; Amy L Kaczmarowski; Elizabeth J Cochran; Jennifer Connelly; Scott D Rand; Kathleen M Schmainda; Peter S LaViolette
Journal:  Tomography       Date:  2016-09

6.  Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice.

Authors:  S C Thust; S Heiland; A Falini; H R Jäger; A D Waldman; P C Sundgren; C Godi; V K Katsaros; A Ramos; N Bargallo; M W Vernooij; T Yousry; M Bendszus; M Smits
Journal:  Eur Radiol       Date:  2018-03-13       Impact factor: 5.315

7.  Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma.

Authors:  Takahiro Sasaki; Manabu Kinoshita; Koji Fujita; Junya Fukai; Nobuhide Hayashi; Yuji Uematsu; Yoshiko Okita; Masahiro Nonaka; Shusuke Moriuchi; Takehiro Uda; Naohiro Tsuyuguchi; Hideyuki Arita; Kanji Mori; Kenichi Ishibashi; Koji Takano; Namiko Nishida; Tomoko Shofuda; Ema Yoshioka; Daisuke Kanematsu; Yoshinori Kodama; Masayuki Mano; Naoyuki Nakao; Yonehiro Kanemura
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

8.  Network signatures of survival in glioblastoma multiforme.

Authors:  Vishal N Patel; Giridharan Gokulrangan; Salim A Chowdhury; Yanwen Chen; Andrew E Sloan; Mehmet Koyutürk; Jill Barnholtz-Sloan; Mark R Chance
Journal:  PLoS Comput Biol       Date:  2013-09-19       Impact factor: 4.475

Review 9.  Quantitative magnetic resonance imaging and radiogenomic biomarkers for glioma characterisation: a systematic review.

Authors:  Pohchoo Seow; Jeannie Hsiu Ding Wong; Azlina Ahmad-Annuar; Abhishek Mahajan; Nor Aniza Abdullah; Norlisah Ramli
Journal:  Br J Radiol       Date:  2018-06-29       Impact factor: 3.039

View more
  1 in total

Review 1.  A Survey of Radiomics in Precision Diagnosis and Treatment of Adult Gliomas.

Authors:  Peng Du; Hongyi Chen; Kun Lv; Daoying Geng
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.